Literature DB >> 10467258

Effect of osmolality and anion channel inhibitors on myo-inositol efflux in cultured astrocytes.

R E Isaacks1, A S Bender, C Y Kim, Y F Shi, M D Norenberg.   

Abstract

Recent studies have shown that swelling-activated myo-inositol efflux from rat C6 glioma cells is mediated by a single transport mechanism and most likely by a volume-sensitive anion channel. In those studies, cells were acclimated in hypertonic medium and then swollen by returning the cells to isotonic medium. In the present study, myo-inositol efflux was determined in primary cultures of astrocytes by first incubating the cells in isotonic radiolabelled medium for 2 hr and then placing the cells in either unlabelled isotonic, hypertonic, or hypotonic medium and measuring release with time. Computer analyses of efflux data indicated a two-component system of myo-inositol efflux. The rate constants for the initial fast component for isotonic and hypotonic cells were 0.0398 +/- 0. 005 and 0.0631 +/- 0.0288 min(-1), respectively. The efflux rates of the slow component, while quite small, were severalfold greater with increasing hypotonic media as compared to the cells in isotonic medium. Several anion membrane transport inhibitors were tested to explore the swelling activated efflux mechanism of myo-inositol. Furosemide (0.5 mM), 1,9 dideoxyforskolin (0.1 mM), NPPB (0.1 mM), niflumic acid (0.5 mM), and SITS (0.5 mM) blocked the fast component of myo-inositol efflux by 17, 49, 55, 75, and 93%, respectively. Our results suggest that the fast component of myo-inositol efflux in primary cultures of astrocytes is mediated by anion transporters or channels and that myo-inositol flux contributes to cell volume regulation in cultures of primary astrocytes. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10467258

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  13 in total

Review 1.  Hepatic encephalopathy as a complication of liver disease.

Authors:  S vom Dahl; G Kircheis; D Häussinger
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  Inhibition of ERK and JNK decreases both osmosensitive taurine release and cell proliferation in glioma cells.

Authors:  Mark J Belsey; Andrew R L Davies; Harry J Witchel; Roland Z Kozlowski
Journal:  Neurochem Res       Date:  2007-06-12       Impact factor: 3.996

3.  Central pontine myelinolysis: historical and mechanistic considerations.

Authors:  Michael D Norenberg
Journal:  Metab Brain Dis       Date:  2010-02-25       Impact factor: 3.584

4.  A model of inositol compartmentation in astrocytes based upon efflux kinetics and slow inositol depletion after uptake inhibition.

Authors:  M Wolfson; Y Bersudsky; E Hertz; V Berkin; E Zinger; L Hertz
Journal:  Neurochem Res       Date:  2000-07       Impact factor: 3.996

5.  Ca2+-mediated potentiation of the swelling-induced taurine efflux from HeLa cells: on the role of calmodulin and novel protein kinase C isoforms.

Authors:  B Falktoft; I H Lambert
Journal:  J Membr Biol       Date:  2004-09-15       Impact factor: 1.843

6.  Intracellular delivery of carbohydrates into mammalian cells through swelling-activated pathways.

Authors:  R Reuss; J Ludwig; R Shirakashi; F Ehrhart; H Zimmermann; S Schneider; M M Weber; U Zimmermann; H Schneider; V L Sukhorukov
Journal:  J Membr Biol       Date:  2004-07-15       Impact factor: 1.843

Review 7.  Organic osmolytes in hyponatremia and ammonia toxicity.

Authors:  Jessica Heins; Claudia Zwingmann
Journal:  Metab Brain Dis       Date:  2010-03-02       Impact factor: 3.584

8.  1H MRS identifies symptomatic and asymptomatic subjects with partial ornithine transcarbamylase deficiency.

Authors:  A L Gropman; S T Fricke; R R Seltzer; A Hailu; A Adeyemo; A Sawyer; J van Meter; W D Gaillard; R McCarter; M Tuchman; M Batshaw
Journal:  Mol Genet Metab       Date:  2008-07-26       Impact factor: 4.797

Review 9.  Brain amino acids during hyponatremia in vivo: clinical observations and experimental studies.

Authors:  Lourdes Massieu; Teresa Montiel; Georgina Robles; Octavio Quesada
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

10.  1H MRS allows brain phenotype differentiation in sisters with late onset ornithine transcarbamylase deficiency (OTCD) and discordant clinical presentations.

Authors:  Andrea L Gropman; Rebecca R Seltzer; Marc Yudkoff; Alice Sawyer; John VanMeter; Stanley T Fricke
Journal:  Mol Genet Metab       Date:  2008-02-11       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.